Physician profile
Zorik Spektor
NPI 1861572828
$80,860.97
in general payments reported to CMS, 2019-2025
8 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $930 · 2022: $19K · 2023: $34K · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $13K · Consulting Fee: $12K · Food and Beverage: $2,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,893.75 |
| Travel and Lodging | $13,213.93 |
| Consulting Fee | $11,812.50 |
| Food and Beverage | $2,078.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $79,765.38 | 2019-2025 | Rapid Rhino, Coblation, Tula |
| Karl Storz Endoscopy-America | $875.00 | 2020 | |
| Stryker Corporation | $110.05 | 2020-2024 | Latera, Clarifix Cryotherapy Device, Xpress Loprofile |
| Cook Medical LLC | $24.51 | 2020 | |
| Integra Lifesciences Corporation | $24.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.06 | 2019 | |
| Aerin Medical INC. | $20.06 | 2019-2020 | |
| Covidien LP | $17.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zorik Spektor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.